May 6, 2026 06:34AM

Apr 15, 2026 03:34PM

Feb 25, 2026 12:03PM

Feb 25, 2026 07:25AM

Feb 14, 2026 10:00AM

Dec 17, 2025 02:14AM

Nov 5, 2025 06:38AM Recursion Pharmaceuticals, Inc. (RXRX) Tops Q3 EPS by 1c

Sep 8, 2025 07:01AM

Aug 5, 2025 06:38AM

Jul 28, 2025 07:00AM

Jul 8, 2025 08:03AM

Jul 3, 2025 04:19AM

Jun 16, 2025 07:35AM

Jun 10, 2025 06:21AM Recursion Pharmaceuticals (RXRX) to cut 20% staff

Jun 6, 2025 10:01AM

May 6, 2025 03:18PM

May 6, 2025 05:40AM

May 5, 2025 06:31AM

Apr 16, 2025 08:42AM

Apr 8, 2025 08:04AM

Mar 18, 2025 08:03AM Recursion Pharmaceuticals (RXRX) Appoints Namandjé Bumpus and Elaine Sun to its Board

Feb 28, 2025 02:06PM

Feb 28, 2025 06:36AM

Feb 18, 2025 11:10AM

Feb 5, 2025 05:27PM

Jan 7, 2025 09:15AM

Dec 20, 2024 05:00AM

Nov 20, 2024 03:13PM KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX)

Nov 13, 2024 09:09AM

Nov 12, 2024 04:55PM

Nov 7, 2024 04:32PM

Oct 22, 2024 08:03AM

Oct 2, 2024 02:17PM

Oct 2, 2024 08:02AM

Sep 4, 2024 07:12AM Recursion Pharmaceuticals (RXRX) PT Lowered to $11 at Needham

Sep 3, 2024 03:00PM

Sep 3, 2024 02:54PM

Sep 3, 2024 11:50AM

Sep 3, 2024 08:19AM

Sep 3, 2024 08:00AM

Aug 8, 2024 07:41AM

Aug 8, 2024 07:37AM Recursion Pharmaceuticals, Inc. (RXRX) Misses Q2 EPS by 2c

Jul 9, 2024 05:17AM

Jun 27, 2024 05:45AM

Jun 26, 2024 04:56PM

Jun 26, 2024 04:07PM

Jun 26, 2024 08:59AM

404,613 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All